Today's Top Gainer
| SYMBOL | CMP | Chg (%) |
|---|---|---|
Note:Top Gainer - Nifty 50 More
Morepen Laboratories Ltd - Share Price
MOREPENLAB
Financials
News & Updates
Morepen Labs adds three new drugs Rivaroxaban, Vildagliptin and UDCA to its API portfolio
Oct 14,2019 10:09 AM
The three bulk drugs / APis are Rivaroxaban (trade name Xarelto), Vildagliptin (trade names- Galvus, Zomelis) and UDCA (Ursodeoxyc
Morepen Labs slumps 17% as Sebi prohibits co.'s access to capital markets for a year Sep 25,2019
Morepen Labs surges after USFDA grants twin approvals Jul 30,2018
Morepen Lab gets USFDA clearance for drug; stock up 15% Dec 20,2017
Morepen Laboratories breaches upper circuit Sep 07,2017
Morepen Laboratories jumps 5.4%; in talks to sell its OTC business Sep 23,2016
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 427.00 | 39.17 | 102,451.60 | 823.16 | 0.64 | 3,215.01 | 98.33 |
| Dr Reddys Laboratories Ltd | 2,908.75 | 19.21 | 48,330.52 | 1,365.10 | 0.69 | 3,435.30 | 852.70 |
| Divis Laboratories Ltd | 1,806.30 | 37.20 | 47,952.92 | 352.83 | 0.89 | 1,403.92 | 266.77 |
| Cipla Ltd | 447.90 | 15.29 | 36,098.73 | 737.38 | 0.67 | 3,230.08 | 209.72 |
| Biocon Ltd | 289.20 | 116.73 | 34,740.00 | 106.10 | 0.17 | 523.90 | 59.29 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Summary & Reports
No Company Summary found
Registered Office
Morepen Village,Nalagarh Road Near Baddi,Solan, Himachal Pradesh,173205
Tell. : +91-01795-46401-3
Website : http://www.morepen.com
Email : corporate@morepen.com
Registrar Office
T-34 2nd Floor, Phase II, New Delhi - 110020 INDIA
Tell. : +91-011-26387281/83
Website : www.masserv.com
Email : info@massere.com
Reports by morepen-laboratories-ltd
Latest Release by morepen-laboratories-ltd
Result Express
Shareholding Snapshot
Loading ...
| Sep - 2019 | |
|---|---|
| Promoter | - |
| Foreign | 0.00% |
| Indian | 34.54% |
| Total Promoter | 34.54% |
| Non Promoter | - |
| Institutions | 14.67% |
| Non-Institutions | 50.79% |
| Total Non-Promoter | 65.46% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Board Meeting
Exp. Date
13 Nov 2019
Annc. Date
06 Nov 2019
MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company ... More
Purpose
EGM
Exp. Date
19 Oct 2019
Annc. Date
24 Sep 2019
EGM 19/10/2019Pursuant to Regulation 30 read with Part A of Schedule III of the Securities Exchange ... More
Purpose
Board Meeting
Exp. Date
19 Sep 2019
Annc. Date
16 Sep 2019
MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company ... More
